Identification of novel interactions between domains of myosin binding protein-C that are modulated by hypertrophic cardiomyopathy missense mutations

Circulation Research

Volumn 91, Issue 8, 2002, Pages 704-711

  Moolman Smook, Johanna ^a   Flashman, Emily ^a   De Lange, Willem ^a   Li, Zhili ^a   Corfield, Valerie ^a   Redwood, Charles ^a   Watkins, Hugh ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Cardiac myosin binding protein C; Hypertrophic cardiomyopathy; Ligand binding; Missense mutations

Indexed keywords

MYOSIN BINDING PROTEIN C;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DIMERIZATION; DNA LIBRARY; HYPERTROPHIC CARDIOMYOPATHY; MISSENSE MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN STRUCTURE; TWO HYBRID SYSTEM;

BINDING SITES; CARDIOMYOPATHY, HYPERTROPHIC; CARRIER PROTEINS; ESCHERICHIA COLI; GENE LIBRARY; HUMANS; KINETICS; LIGANDS; MUTATION, MISSENSE; PROTEIN STRUCTURE, TERTIARY; SACCHAROMYCES CEREVISIAE; SEQUENCE DELETION; SURFACE PLASMON RESONANCE; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 0037131207     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000036750.81083.83     Document Type: Article

References (44)

1. Offer G, Moos C, Starr R. A new protein of the thick filaments of vertebrate skeletal myofibrils Extractions, purification and characterization. J Mol Biol. 1973;74:653-676.
2. Bennett P, Craig R, Starr R, Offer G. The ultrastructural location of C-protein, X-protein and H-protein in rabbit muscle. J Muscle Res Cell Motil. 1986;7:550-567.
3. Bennett PM, Furst DO, Gautel M, The C-protein (myosin binding protein C) family: Regulators of contraction and sarcomere formation? Rev Physiol Biochem Pharmacol. 1999;138:203-234.
4. Winegrad S. Cardiac myosin binding protein C. Circ Res. 1999;84:1117-1126.
5. Weber FE, Vaughan KT. Reinach FC, Fischman DA. Complete sequence of human fast-type and slow-type muscle myosin-binding-protein C (MyBP-C): Differential expression, conserved domain structure and chromosome assignment. Eur J Biochem. 1993;216:661-669.
6. Gautel M, Zuffardi O, Freiburg A, Labeit S. Phosphorylation switches specific for the cardiac isoform of myosin binding protein-C: A modulator of cardiac contraction? EMBO J. 1995;14:1952-1960.
7. Okagaki T, Weber FE, Fischman DA, Vaughan KT, Mikawa T, Reinach FC. The major myosin-binding domain of skeletal muscle MyBP-C (C protein) resides in the COOH-terminal, immunoglobulin C2 motif. J Cell Biol. 1993;123:619-626.
8. Freiburg A, Gautel M. A molecular map of the interactions between titin and myosin-binding protein C. Implications for sarcomeric assembly in familial hypertrophic cardiomyopathy. Eur J Biochem. 1996;235:317-323.
9. Gilbert R, Cohen JA, Pardo S, Basu A, Fischman DA. Identification of the A-band localization domain of myosin binding proteins C and H (MyBP-C, MyBP-H) in skeletal muscle. J Cell Sci. 1999;112(Pt 1):69-79.
10. Hartzell HC, Titus L. Effects of cholinergic and adrenergic agonists on phosphorylation of a 165,000-dalton myofibrillar protein in intact cardiac muscle. J Biol Chem. 1982;257:2111-2120.
11. Gruen M, Gautel M. Mutations in β-myosin S2 that cause familial hypertrophic cardiomyopathy (FHC) abolish the interaction with the regulatory domain of myosin-binding protein-C. J Mol Biol. 1999;286:933-949.
12. Gruen M, Prinz H, Gautel M. cAPK-phosphorylation controls the interaction of the regulatory domain of cardiac myosin binding protein C with myosin-S2 in an on-off fashion. FEBS Lett. 1999;453:254-259.
13. Weisberg A, Winegrad S. Relation between crossbridge structure and actomyosin ATPase activity in rat heart. Circ Res. 1998;83:60-72.
14. Levine R, Weisberg A, Kulikovskaya I, McClellan G, Winegrad S. Multiple structures of thick filaments in resting cardiac muscle and their influence on cross-bridge interactions. Biophys J. 2001;81:1070-1082.
15. Witt CC, Gerull B, Davies MJ, Centner T, Linke WA, Thierfelder L. Hypercontractile properties of cardiac muscle fibers in a knock-in mouse model of cardiac myosin-binding protein-C. J Biol Chem. 2001;276:5353-5359.
16. Thierfelder L, Watkins H, MacRae C, Lamas R, McKenna W, Vosberg HP, Seidman JG, Seidman CE. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomere. Cell. 1994;77:701-712.
17. DNA Mutation Database: Familial Hypertrophic Cardiomyopathy. Australian National Genomic Information Service. Available at: http://morgan.angis.su.oz.au/Databases/Heart/heartbreak.html. Accessed August 28, 2002.
18. Redwood CS, Moolman-Smook JC, Watkins H. Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy. Cardiovasc Res. 1999;44:20-36.
19. Watkins H, Conner D, Thierfelder L, Jarcho JA, MacRae C, McKenna WJ, Maron BJ, Seidman JG, Seidman CE. Mutations in the cardiac myosin binding protein-C gene on chromosome II cause familial hypertrophic cardiomyopathy. Nat Genet. 1995;11:434-437.
20. Bonne G, Carrier L, Bercovici J, Cruaud C, Richard P, Hainque B, Gautel M, Labeit S, James M, Beckmann J, Schwartz K. Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nat Genet. 1995;11:438-440.
21. Niimura H, Bachinski LL, Sangwatanaroj S, Watkins H, Chudley AE, McKenna W, Kristinsson A, Roberts R, Sole M, Maron BJ, Seidman JG, Seidman CE. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med. 1998;338:1248-1257.
22. Flavigny J, Souchet M, Sebillon P, Berrebi-Bertrand I, Hainque B, Mallet A. Bril A, Schwartz K, Carrier L, COOH-terminal truncated cardiac myosin-binding protein C mutants resulting from familial hypertrophic cardiomyopathy mutations exhibit altered expression and/or incorporation in fetal rat cardiomyocytes. J Mol Biol. 1999;294:443-456.
23. Yang Q, Sanbe A, Osinska H, Hewett TE, Klevitsky R, Robbins J. In vivo modeling of myosin binding protein C familial hypertrophic cardiomyopathy. Circ Res. 1999;85:841-847.
24. Moolman-Smook JC, Mayosi B, Brink P, Corfield VA. Identification of a new missense mutation in MyBP-C associated with hypertrophic cardiomyopathy. J Med Genet. 1998;35:253-254.
25. Moolman-Smook JC, De Lange WJ, Bruwer EC, Brink PA, Corfield VA. The origins of hypertrophic cardiomyopathy-causing mutations in two South African subpopulations: A unique profile of both independent and founder events. Am J Hum Genet. 1999;65:1308-1320.
26. Yu B, French JA, Carrier L, Jeremy RW, McTaggart DR, Nicholson MR, Hambly B, Semsarian C, Richmond DR, Schwartz K, Trent RJ. Molecular pathology of familial hypertrophic cardiomyopathy caused by mutations in the cardiac myosin binding protein C gene. J Med Genet. 1998;35:205-210.
27. Niimura H, Patton KK, McKenna WJ, Soults J, Maron BJ, Seidman JG, Seidman CE. Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly. Circulation. 2002;105:446-451.
28. Elliott K, Watkins H, Redwood CS. Altered regulatory properties of human cardiac troponin I mutants that cause hypertrophic cardiomyopathy. J Biol Chem. 2000;275:22069-22074.
29. BLAST Database. National Center for Biotechnology Information Web Site. Available at: http://ncbi.nlm.nih.gov/blast. Accessed August 28, 2002.
30. Way M, Gooch J, Pope B, Weeds AG. Expression of human plasma gelsolin in Escherichia coli and dissection of actin binding sites by segmental deletion mutagenesis. J Cell Biol. 1989;109:593-605.
31. Kiselyov VV, Berezin V, Maar TE, Soroka V, Edvardsen K, Schousboe A, Bock E. The first immunoglobulin-like neural cell adhesion molecule (NCAM) domain is involved in double-reciprocal interaction with the second immunoglobulin-like NCAM domain and in heparin binding. J Biol Chem. 1997;272:10125-10134.
32. Hartzell HC, Sale WS. Structure of C protein purified from cardiac muscle. J Cell Biol. 1985;100:208-215.
33. Squire J, Cantino M, Chew M, Denny R, Harford J, Hudson L, Luther P. Myosin rod-packing schemes in vertebrate muscle thick filaments. J Struct Biol. 1998;122:128-138.
34. Liversage AD, Holmes D, Knight PJ, Tskhovrebova L, Trinick J. Titin and the sarcomere symmetry paradox. J Mol Biol. 2001;305:401-409.
35. Moos C, Offer G, Starr R, Bennett P. Interaction of C-protein with myosin, myosin rod and light meromyosin. J Mol Biol. 1975;97:1-9.
36. Starr R, Offer G. The interaction of C-protein with heavy meromyosin and subfragment-2. Biochem J. 1978;171:813-816.
37. Pfuhl M, Pastore A. Tertiary structure of an immunoglobulin-like domain from the giant muscle protein titin: A new member of the I set. Structure. 1995;3:391-401.
38. Offer G. C-protein and the periodicity in the thick filaments of vertebrate skeletal muscle. CSH Symp Quant Biol. 1972;37:87-95.
39. Swan RC, Fischman DA. Electron microscopy of C-protein molecules from chicken skeletal muscle. J Muscle Res Cell Motil. 1986;7:160-166.
40. Bennett P, Starr R, Elliott A, Offer G. The structure of C-protein and X-protein molecules and a polymer of X-protein. J Mol Biol. 1985;184:297-309.
41. Luther P. Three dimensional structure of the A-band and localization of MyBPC-C. Biophys J. 1998;74:A352. Abstract.
42. Montgomery DE, Tardiff JC, Chandra M. Cardiac troponin T mutations: Correlation between the type of mutation and the nature of myofilament dysfunction in transgenic mice. J Physiol. 2001;536:583-592.
43. Yu B, French JA, Jeremy RW, French P, McTaggart DR, Nicholson MR, Semsarian C, Richmond DR, Trent RJ. Counselling issues in familial hypertrophic cardiomyopathy. J Med Genet. 1998;35:183-188.
44. Idowu SM, Gautel M, Pfuhl M. Sequence specific resonance assignment of the central domain of cardiac myosin binding protein C (MyBP-C). J Biomol NMR. 2002;22:199-200.